2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34856074 | Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment. | 2022 Mar | 2 |
2 | 32876513 | IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer. | 2021 Mar | 1 |